Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation.

HLA·2025
Same author

Insights into the localized corrosion initiation mechanisms of alloy 718.

Heliyon·2025
Same author

Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis.

European urology focus·2024
Same author

Appropriateness of prescribing profiles and intake adherence to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: analysis of a retrospective longitudinal study using real-world data from Northern Portugal (AF-React Study).

BMJ open·2024
Same author

AF-React study: Prevalence of thrombotic events in patients with atrial fibrillation receiving NOACs - real-world data analysis from northern Portugal primary healthcare.

Frontiers in medicine·2024
Same author

Exploring the electrical robustness of conductive textile fasteners for wearable devices in different human motion conditions.

Scientific reports·2024

Related Experiment Video

Updated: Jul 19, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K

Equity matrix for kidney transplant allocation.

Bruno A Lima1, Filipe Reis1, Helena Alves1

  • 1Oficina de Bioestatistica, Transplant Open Registry, Ermesinde, Portugal.

Transplant Immunology
|August 11, 2023
PubMed
Summary
This summary is machine-generated.

The proposed Equity Matrix (EQM) kidney allocation system offers a more equitable distribution of organs than the Eurotransplant (ET) system. EQM prioritizes factors like dialysis time and reduces human leukocyte antigen mismatches for better transplant outcomes.

Keywords:
Equity and utilityKidney allocation systemRenal transplantationWait-list

More Related Videos

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.6K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K

Related Experiment Videos

Last Updated: Jul 19, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.6K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K

Area of Science:

  • Nephrology
  • Transplantation Science
  • Medical Ethics

Background:

  • Kidney allocation systems must balance transplant utility with justice and transparency.
  • Existing systems face challenges in achieving equitable organ distribution.
  • Continuous improvement of kidney allocation policies is essential.

Purpose of the Study:

  • To introduce a novel kidney allocation system, the Equity Matrix (EQM), designed to balance utility and justice criteria.
  • To compare the EQM system against established models like the Eurotransplant (ET) kidney allocation system.
  • To evaluate the impact of different allocation models on key recipient and donor characteristics.

Main Methods:

  • Generation of synthetic data for 2000 transplant candidates and 280 donors.
  • Simulation of 1000 kidney allocation iterations using the ET system and the proposed EQM system.
  • Comparative analysis of recipient variables including age difference, Human Leukocyte Antigens (HLA) mismatches, dialysis time, and calculated Panel Reactive Antibodies (cPRA).
  • Statistical comparison using graphical methods and Cohen's d effect size.

Main Results:

  • The ET system allocated more highly sensitized recipients and older donor-recipient pairs with zero HLA mismatches.
  • The EQM neutral model allocated slightly older recipients with smaller age differences and fewer HLA mismatches.
  • EQM recipients demonstrated longer dialysis times and a reduced likelihood of six HLA mismatches compared to ET recipients.

Conclusions:

  • The proposed EQM model provides a transparent and equitable approach to kidney allocation.
  • EQM demonstrates superior performance in balancing key equity and utility metrics compared to established practices.
  • The EQM system offers a promising alternative for optimizing kidney transplantation processes.